Are These Top Penny Stocks On Your Election Day Watch List?
Penny stocks, for the most part, trade on other factors usually unrelated to the broader markets. Today, however, is Election Day in the U.S. Some are referring to this as “earnings for America”. This is the long-awaited date that traders and investors have been waiting for especially this year. The discussions surrounding this election, in particular, has been heated and, with that, has become a source of incredible volatility. As traders, however, this is what we seek, right? Big moves in stock price are what breeds opportunities for quick profits.
What are going to be the key drivers to take notice of today? Obviously, polling numbers are going to be filtering their way out later in the day. Don’t be surprised to see a wide swing in market levels toward the end of the Tuesday session. You’ve also got to keep in mind some of the prime industries and sectors that have companies in the mix of hot, political topics. Things like energy stocks, biotech stocks, marijuana stocks, and even safety & surveillance stocks will likely hold a spotlight.
Read More
- The Magic Mushroom Boom Is Just Beginning & 1 Company Stands To Capitalize
- Looking For Penny Stocks To Buy Today? 5 Marijuana Stocks To Watch
- Blue Apron Holdings (APRN) Is Officially A Penny Stock; What Happened?
While these are somewhat smaller factors to consider in the grand scheme of the market’s future, we’re talking about penny stocks, remember. These are well-known for being reactive to even the smallest catalyst. If anything, as traders, being able to handle volatility and risk are the main goals. With that in mind, let’s keep an eye on the stock market today and be ready for volatility. In light of this, here are a few penny stocks to watch right now on Election Day.
Top Penny Stocks To Watch: GT Biopharma Inc.
GT Biopharma Inc. (GTBP Stock Report) has been one of the top biotech penny stocks to watch recently. For the better part of the past 6 weeks, trading action has been picking up. Both price and volume have experienced a clear increase during that time, which also coincides with the company’s string of key updates.
Most had centered around the company’s pipeline treatments, specifically, results related to its lead treatment for acute myeloid leukemia, GTB-3550. In fact, interim results from its Phase I/II trials were chosen for presentation at the upcoming ASH conference. So that will definitely be something to keep in mind as that conference gets closer.
GTB-3550 is based on the company’s TriKE technology. The platform was designed to address myriad cancers as a combination protein that bridges an immune cell and a tumor cell. The idea is that this would drive tumor cell killing power exponentially. But it hasn’t just been about GTB-3550. A recent publication in the journal Cancers suggested a TriKE targeted treatment could justify the advancement for treating certain tumor cells.
In this light, TriKE has been evaluated in ovarian, breast, prostate, pancreatic ductal adenocarcinoma, and lung cancer models. With the potential presented in TriKE, along with the progress and upcoming presentation on GTB-3550, GTBP remains a biotech penny stock to watch.
Top Penny Stocks To Watch: Ambow Education Holding Ltd.
Some children might already be heading back to school but that hasn’t prevented technology from advancing virtual learning. Ambow Education Holding Ltd. (AMBO Stock Report) is one of these companies bridging the gap between in-person and virtual learning, specifically in China. This week, Ambow announced a strategic partnership with Cisco to launch online international career education, training, and certification services.
[Read More] Top Penny Stocks To Watch Before Next Week; 1 Up 220% In 2020
The initial focus is on college students and industry professionals. Dr. Jin Huang, President and Chief Executive Officer of Ambow, commented, “The partnership programs, designed to improve activities for educational institutions and end-users, involve cloud training, well-known certifications and job placement, which leverage Ambow’s own patent technology, online and offline systems, and other high-quality global resources.”
You might remember AMBO stock from earlier this year. If you do, you can’t forget how volatile this penny stock was. At the end of September, shares saw an explosive move to highs of $6.43 on some of its highest volume of the year. Soon after, AMBO slid. Heading into Tuesday’s session, will this be the same as before or is a true breakout in the works?
Top Penny Stocks To Watch: Remark Holdings Inc.
One of the other evolutions we’ve seen is how people will get back to “the new normal”. Everything from additional surveillance to temperature monitoring are up for grabs right now. Remark Holdings Inc. (MARK Stock Report) has remained in the spotlight for speculation on the latter. The company’s focus on thermal imaging has been the biggest source of attention.
Over the past several months, excitement, more or less, turned into confusion. There was a lot of hype back in the summer when the company began tweeting pictures of its monitoring systems at certain locations in Las Vegas. It also coincided with discussions that were being had by several big-name casino operators. Where the confusion and uncertainty come into play is the lack of supporting information. There can only be so many tweets without news or filings until questions arise.
This week, however, MARK stock has begun surging after a formal update. Remark AI was chosen by Morton Comprehensive Health Services to offer temperature monitoring solutions. Kai-Shing Tao, Chairman and Chief Executive Officer of Remark Holdings said, “Our biosafety platform alleviates the need for keeping a valuable staff member off the floor and provides a discreet and seamless experience for temperature checks, PPE compliance, tracking temperature data, and protecting both staff and patients.”
Something else to note is that Remark is adjourning its special shareholder meeting tomorrow (11/4). The main point of focus was to gain approval for increasing its authorized share count to 175 million. Will that eventually pose certain risks ahead such as dilution risk in the event the goal is to raise money?
Pursuant to an agreement between Midam Ventures LLC and GT Biopharma (GTBP), GT Biopharma is required to pay $200,000 per month for 4 months of services, $400,000 of which has already been paid for 2 months of services (first and last month) for a period from September 22, 2020 to January 22, 2021. We may buy or sell additional shares of GT Biopharma (GTBP) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about GT Biopharma (GTBP).
